This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cyclophosphamide and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (5354)
Death (1301)
Life Threatening Events (409)
Disability (128)
Reports by Reaction Type
Febrile Neutropenia (521),
Neutropenia (401),
Pyrexia (278),
Infection (257),
Pneumonia (246),
Anaemia (235),
Death (204),
Thrombocytopenia (204),
Sepsis (196),
Nausea (171),
Diarrhoea (171),
Toxicity To Various Agents (146)
Below are a few examples of reports where side effects / adverse reactions may be related to Cyclophosphamide. For a complete list or a specific selection of reports, please use the links above.
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Intussusception, Anaemia, Chronic Obstructive Pulmonary Disease, Renal Failure Chronic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-08-16
End date: 2012-01-03
Fludarabine Phosphate
Dosage: day1, 2, 3 q month
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-08-16
End date: 2012-01-05
Cyclophosphamide
Dosage: day1, 2, 3 q month
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-08-16
End date: 2012-01-05
Possible Cyclophosphamide side effects in female
Reported by a physician from Switzerland on 2012-08-27
Patient: female, weighing 87.7 kg (192.9 pounds)
Reactions: Cholecystitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Rituximab
Dosage: concentration 1/mg/ml
Start date: 2011-11-11
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-11
Prednisolone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-12
Other drugs received by patient: Pantoprazole; Exforge HCT; Dipyrone INJ; Bisoprolol Fumarate; Domperidon; Bactrim DS; Acetaminophen; Metformin Hydrochloride
Possible Cyclophosphamide side effects in 57 year old female
Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-08-27
Patient: 57 year old female
Reactions: Breast Cancer Metastatic, Paraneoplastic Dermatomyositis, Pulmonary Embolism
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: 6 cycles
Indication: Breast Cancer
Capecitabine
Administration route: Oral
Indication: Breast Cancer
Cisplatin
Dosage: 6 cycles
Indication: Breast Cancer
Gemcitabine Hydrochloride
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Cyclophosphamide
Dosage: 6 cycles
Indication: Breast Cancer
Possible Cyclophosphamide side effects in 62 year old female
Reported by a physician from Spain on 2012-08-27
Patient: 62 year old female
Reactions: Osteonecrosis
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 600 mg/m2 q21d (4 cycles)
Indication: Breast Cancer
Doxorubicin Hydrochloride
Dosage: 60 mg/m2 q21d (4 cycles)
Indication: Breast Cancer
Anastrozole
Dosage: 1 mg/day
Indication: Breast Cancer
Other drugs received by patient: Dexamethasone; Chlorhexidine Gluconate; Omeprazole
Possible Cyclophosphamide side effects in female
Reported by a physician from Italy on 2012-08-27
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Vomiting, Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 600mgm2 cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-19
Losazid
Dosage: 50mg twice per day
Administration route: Oral
Indication: Hypertension
Start date: 2009-03-29
End date: 2012-07-25
Nipent
Dosage: 2mgm2 cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-19
Arzerra
Dosage: 300mg cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-20
Other drugs received by patient: Allopurinol; Sulfamethoxazole and Trimethoprim
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27
Patient: male
Reactions: Dystonia, Encephalopathy, Parkinsonism
Drug(s) suspected as cause:
Vincristine
Cisplatin
Etoposide
Ifosfamide
Cyclophosphamide
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650 mg/m2, day 1 (4 standard cycles)
Prednisolone
Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
Administration route: Oral
Doxorubicin HCL
Dosage: 25 mg/m2, day 1 (4 standard cycles)
Etoposide
Dosage: 100 mg/m2, day 1-3 (4 standard cycles)
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
Administration route: Oral
Etoposide
Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 35 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Prednisolone
Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (4 standard cycles)
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (4 standard cycles)
Cyclophosphamide
Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Possible Cyclophosphamide side effects in 79 year old female
Reported by a physician from Germany on 2012-08-27
Patient: 79 year old female
Reactions: Sciatica, Lumbar Vertebral Fracture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Vincristine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Prednisone
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Possible Cyclophosphamide side effects in 47 year old male
Reported by a physician from France on 2012-08-27
Patient: 47 year old male
Reactions: Respiratory Tract Infection Bacterial, Epstein-Barr Virus Associated Lymphoma, Congestive Cardiomyopathy, Systolic Dysfunction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisolone
Administration route: Oral
Start date: 2012-06-08
Nexium
Administration route: Oral
Cyclophosphamide
Start date: 2012-06-08
Doxorubicin HCL
Start date: 2012-06-11
End date: 2012-07-10
Mabthera
Start date: 2012-06-11
Vincristine
Start date: 2012-06-08
Other drugs received by patient: Previscan; Methotrexate Sodium; Potassium Chloride; Kineret; Kineret; Kineret; Cacit D3; Aspirin; Prednisone TAB; Acetaminophen; Acetaminophen W / Codeine; Alendronate Sodium / Cholecalciferol
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection
Drug(s) suspected as cause:
Etoposide
Indication: Retinoblastoma
Cyclophosphamide
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Doxorubicin Hydrochloride
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Cyclophosphamide side effects in female
Reported by a physician from United States on 2012-08-27
Patient: female, weighing 84.9 kg (186.8 pounds)
Reactions: Breast Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-15
End date: 2012-08-01
Avastin
Dosage: last dose prior to event - 27/jul/2012
Indication: Breast Cancer
Start date: 2012-06-15
Cyclophosphamide
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-15
End date: 2012-08-01
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: male
Reactions: Abscess Neck
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Cisplatin
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Doxorubicin Hydrochloride
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Cyclophosphamide
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Etoposide
Dosage: unk
Indication: Multiple Myeloma
End date: 2011-06-21
Possible Cyclophosphamide side effects in 10 year old male
Reported by a physician from United States on 2012-08-27
Patient: 10 year old male, weighing 76.1 kg (167.4 pounds)
Reactions: Hypersensitivity, Hyperglycaemia, Peripheral Motor Neuropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-05-22
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
PEG-Asparaginase
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-06
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Other drugs received by patient: Radiation
Possible Cyclophosphamide side effects in male
Reported by a physician from Netherlands on 2012-08-27
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Cranial Nerve Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: third maintenance cycle
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-06
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: third maintenance cycle
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-06
Vincristine
Dosage: third maintenance cycle
Start date: 2010-09-06
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: third maintenance cycle
Administration route: Oral
Start date: 2010-09-06
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Neupogen
Dosage: third maintenance cycle
Start date: 2010-09-07
Doxorubicin HCL
Dosage: third maintenance cycle
Start date: 2010-09-06
Rituximab
Start date: 2010-11-29
End date: 2011-03-21
Possible Cyclophosphamide side effects in male
Reported by a physician from France on 2012-08-27
Patient: male
Reactions: Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-23
Prednisone TAB
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
End date: 2012-05-24
Levoleucovorin Calcium
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-21
End date: 2012-05-25
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Start date: 2012-05-21
End date: 2012-05-21
Vincristine
Start date: 2012-05-25
Mabthera
Indication: Burkitt's Lymphoma
Start date: 2012-05-19
End date: 2012-05-19
Vincristine
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-20
Methotrexate Disodium
Indication: Burkitt's Lymphoma
Start date: 2012-05-20
Methotrexate Disodium
Start date: 2012-05-25
Other drugs received by patient: Cytarabine; Calciparine; Ondansetron Hydrochloride; Allopurinol; Valaciclovir HCL; Nexium; Lyrica; Bactrim DS; Emend
Possible Cyclophosphamide side effects in
Reported by a physician from Germany on 2012-08-27
Patient:
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
Ofatumumab
Indication: Chronic Lymphocytic Leukaemia
Possible Cyclophosphamide side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Cyclophosphamide side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin Hydrochloride
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir
Possible Cyclophosphamide side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 52 year old female
Reactions: Tumour Lysis Syndrome, Posterior Reversible Encephalopathy Syndrome, Insomnia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Methylprednisolone Sodium Succinate
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: at 50% dosage
Prednisone TAB
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Dexamethasone
Indication: Premedication
Vincristine
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Cyclophosphamide
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Other drugs received by patient: Ondansetron; Voriconazole; Morphine Sulfate; Morphine
Possible Cyclophosphamide side effects in female
Reported by a physician from France on 2012-08-24
Patient: female
Reactions: Burning Sensation, Skin Exfoliation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-06
End date: 2012-07-06
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-06
End date: 2012-07-08
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-06
End date: 2012-07-08
Possible Cyclophosphamide side effects in 64 year old male
Reported by a physician from Germany on 2012-08-24
Patient: 64 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Bacterial Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Start date: 2011-07-18
Fludarabine Phosphate
Start date: 2011-07-19
Cyclophosphamide
Start date: 2011-07-19
Other drugs received by patient: Prednisolone; Acyclovir
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-24
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-24
Patient: male, weighing 26.9 kg (59.2 pounds)
Reactions: Tachycardia, Fungal Sepsis, Status Epilepticus, Oral Candidiasis, Hypomagnesaemia, Acute Respiratory Distress Syndrome, Bradycardia, Neutropenia, Blood Pressure Decreased, Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Isotretinoin
Dosage: 80 mg
C-CSF (Filgrastim, Amgen)
Dosage: 135 mg
Vincristine Sulfate
Dosage: 2.8 mg
Cisplatin
Dosage: 74 mg
Cyclophosphamide
Dosage: 1960 mg
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 121.9 kg (268.2 pounds)
Reactions: Pruritus, Unresponsive To Stimuli, Device Related Infection, Pyrexia, Candidiasis, Abscess Limb, Ventricular Extrasystoles, Metabolic Acidosis, Dyspnoea, Hypotension, Pancytopenia, Tremor, Convulsion, Respiratory Failure, Fungal Infection, Ventricular Tachycardia, Sepsis, Respiratory Arrest, Pulse Absent, Sinus Tachycardia, Hypertension, Feeling Abnormal, Cardiac Arrest, Escherichia Infection, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epinephrine
Dosage: 4 df, unk
Indication: Cardiac Arrest
Start date: 2012-07-14
End date: 2012-07-14
Cyclophosphamide
Dosage: daily for 5 days
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Oncaspar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Epinephrine
Dosage: unk
Start date: 2012-07-14
End date: 2012-07-14
Clolar
Dosage: 74.4 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Vincristine Sulfate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Other drugs received by patient: Colace; Bactrim; Stomatitis Mouthwash; Prilosec; Lortab; Cymbalta; Ondansetron; Ambien
Possible Cyclophosphamide side effects in 52 year old female
Reported by a physician from United Kingdom on 2012-08-24
Patient: 52 year old female, weighing 83.3 kg (183.3 pounds)
Reactions: Neutropenic Sepsis, Pyrexia, Diarrhoea Infectious
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 mg/m2, every 3 weeks
Indication: Breast Cancer
Start date: 2012-07-02
Fluorouracil
Dosage: 500 mg, every 3 weeks
Indication: Breast Cancer
Start date: 2012-07-02
Epirubicin Hydrochloride
Dosage: 100 mg/m2, every 3 weeks
Indication: Breast Cancer
Start date: 2012-07-02
Fluorouracil
Dosage: 1000 mg/m2, every 3 weeks
Pertuzumab
Indication: Breast Cancer
Epirubicin Hydrochloride
Dosage: 200 mg/m2, every 3 weeks
Cyclophosphamide
Dosage: 1000 mg/m2, every 3 weeks
Trastuzumab
Indication: Breast Cancer
Possible Cyclophosphamide side effects in female
Reported by a physician from Thailand on 2012-08-24
Patient: female, weighing 57.4 kg (126.3 pounds)
Reactions: Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Doxorubicin Hydrochloride
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Mabthera
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Cyclophosphamide
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Vincristine
Indication: B-Cell Lymphoma
Start date: 2012-03-02
Other drugs received by patient: Dexamethasone; Acetaminophen; Ondansetron; Metformin HCL; Ondansetron; Ondansetron; Atenolol; Simvastatin; Benadryl
Possible Cyclophosphamide side effects in 51 year old male
Reported by a physician from Germany on 2012-08-24
Patient: 51 year old male
Reactions: Progressive Multifocal Leukoencephalopathy
Drug(s) suspected as cause:
Mabthera
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Prednisone
Indication: HIV Infection
Cyclophosphamide
Indication: HIV Infection
Doxorubicin HCL
Indication: HIV Infection
Mabthera
Indication: HIV Infection
Vincristine
Indication: HIV Infection
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 103.1 kg (226.8 pounds)
Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Radiation Therapy NOS
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Revlimid
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Cisplatin
Indication: Multiple Myeloma
Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide
Possible Cyclophosphamide side effects in female
Reported by a physician from Bulgaria on 2012-08-24
Patient: female, weighing 63.0 kg (138.6 pounds)
Reactions: Circulatory Collapse, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 milligram
Indication: Multiple Myeloma
Start date: 2012-05-23
End date: 2012-05-25
Doxorubicin Hydrochloride
Dosage: 80 milligram
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-26
Dexamethasone
Dosage: 40 milligram
Start date: 2012-06-02
End date: 2012-06-05
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-30
End date: 2012-06-07
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Start date: 2012-05-23
End date: 2012-05-26
Vincristine
Dosage: 2 milligram
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-06-02
Dexamethasone
Dosage: 20 milligram
Start date: 2012-05-16
End date: 2012-05-19
Other drugs received by patient: Milgamma; Dopamine HCL; Nexium; Atropine; Sodium Carbonate; Lyrica; Uromithexane; Electrolyte Infusions; Sodium Bicarbonate; Probitor; Tevagrastim
|
